Trump Says US Companies Discussed Treatment for Boris Johnson With UK Doctors

President Donald Trump said that U.S. pharmaceutical companies have discussed “recently developed” treatment for UK Prime Minister Boris Johnson, who was admitted to intensive care on Monday afternoon with the CCP virus.

Johnson was diagnosed with the CCP (Chinese Communist Party) virus, also known as the novel coronavirus, on March 27. His condition worsened over Monday afternoon and he was moved to intensive care on the advice of his medical team.

Although the UK prime minister had received oxygen, his office said on Monday he was still conscious and was moved to intensive care just in case he needed to be put on a ventilator.

“Hes not on a ventilator no,” Cabinet Office Minister Michael Gove told LBC radio on Tuesday. “The prime minister has received some oxygen support and he is kept under, of course, close supervision.”

Trump said Monday night that he asked two leading U.S. companies to contact London immediately.

“These are brilliant companies—Ebola, AIDS, others—theyve come with the solutions and just have done incredible jobs … They have offices in London, major companies. More than major, more than size, theyre genius,” the president said of the companies.

Related CoverageTrump Says US Companies Discussed Treatment for Boris Johnson With UK DoctorsUK Prime Minister Taken to Hospital ICU Over COVID-19

Trump added that he had spoken to four companies and that he understands that they “have really advanced therapeutics.”

“They have arrived in London already,” Trump said. “Their London office has whatever they need and we will see if we can be of help—we have contacted all of Boriss doctors and we will see what is going to take place. But they are ready to go … The two companies are there and with what they are talking about—and it is rather complex and has had really incredible results—we are working with the FDA and everybody else but we are working with London with respect to Boris Johnson.”

Earlier in the day, Trump spoke by telephone with CEOs of four pharmaceutical companies—Amgen, Genetech, Gilead, and Regeneron.

“The president acknowledged the industrys progress in developing therapeutics to fight this pandemic and promised the federal government will continue to be a helpful partner with science and data leading the way,” White House Deputy Press Secretary Judd Deere said in a statement. “The executives thanked President Trump for directing his administration to break down barriers, cut red tape, and encourage cooperation across all industries and government to best meet the needs of the American people during this unprecedented time.”

A reporter asked Trump about what treatment was discussed for Johnson, and whether the treatment is available to the American public.

“Its a very complex treatment of things that theyve just recently developed, and that they have a lot of experience with having to do with something else—but recent for this. Theyve already concurred, theyve already had meetings with the doctors and well see whether or not they want to go that route,” Trump responded.

“I think we have three of them. I spoke with four. You know who the four would be,” Trump said, without naming the companies at the press conference.

Trump also expressed well-wishes and praised the UK prime minister.

“I want to send best wishes to a very good friend of mine and a friend to our nation, Prime Minister Boris Johnson,” Trump said. “He has been a really good friend, something very special—strong, resolute, doesnt quit, doesnt give uRead More – Source

Show More

Related Articles